ClinicalTrials.Veeva

Menu

Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care

The Ohio State University logo

The Ohio State University

Status

Completed

Conditions

Lip and Oral Cavity Squamous Cell Carcinoma
Stage 0 Lip and Oral Cavity Cancer
Tongue Cancer
Oral Cavity Verrucous Carcinoma

Treatments

Procedure: fluorescence imaging
Procedure: examination
Procedure: Comparison of surgical margins by COE vs. DVFE
Procedure: biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT01816841
NCI-2012-02017 (Registry Identifier)
OSU-08095

Details and patient eligibility

About

This clinical trial studies direct visual fluorescence in finding oral cancer in high-risk patients and patients undergoing routine dental care. Diagnostic procedures, such as direct visual fluorescence, may help find and diagnose oral cancer.

Full description

PRIMARY OBJECTIVES:

I. To assess the diagnostic benefit of the VELscope (direct visual fluorescence) inspection in oral examination.

II. Efficacy of the VELscope in identifying dysplastic (premalignant) and malignant oral mucosal lesions and in discriminating these lesions from common benign tissue changes.

III. Accuracy of clinical judgment versus VELscope findings. IV. Ability of the VELscope to identify lesions or extent of lesions beyond what is clinically apparent.

OUTLINE:

Patients undergo conventional oral examination (COE) followed by direct visual fluorescence examination (DVFE). Patients with tissue abnormalities found by COE or DVFE undergo scalpel biopsy within 2 weeks.

Enrollment

68 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • HIGH-RISK POPULATION:
  • 33 consecutive consenting patients presenting to The Ohio State University James Cancer Hospital Otolaryngology Department with a suspicious oral lesion or prior biopsy-confirmed epithelial dysplasia (mild, moderate, severe), carcinoma in situ (CIS), or squamous cell carcinoma (SCC) will be recruited; adult patients presenting for initial evaluation for treatment planning and/or presenting for follow-up appointments monitoring for recurrence will be eligible to participate
  • GENERAL POPULATION:
  • 250 consecutive consenting patients presenting to The Ohio State University College of Dentistry for routing dental care will be recruited; adult patients presenting to the screening clinic for initial oral evaluation will be eligible to participate

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

68 participants in 2 patient groups

Diagnostic (COE and DVFE)- Arm I
Experimental group
Description:
Arm I - Patients undergo COE followed by DVFE. Patients with tissue abnormalities found by COE or DVFE undergo biopsy within 2 weeks.
Treatment:
Procedure: biopsy
Procedure: fluorescence imaging
Procedure: examination
Arm II - Comparison of surgical margins using COE vs. DVFE
Experimental group
Description:
Comparison of surgical margins using COE vs. DVFE
Treatment:
Procedure: Comparison of surgical margins by COE vs. DVFE
Procedure: biopsy
Procedure: fluorescence imaging
Procedure: examination

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems